Susan M. Perkins
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan M. Perkins has a total of 200 co-authors. Here are the top co-authors by number of shared publications:
- Assal Habibi
University of Southern California
4 shared publications - Christian Gold
NORCE Norwegian Research Centre AS, Bergan, Norway
4 shared publications - Debra S. Burns
University of Memphis, College of Communication and Fine Arts, Memphis, TN, United States
4 shared publications - Diane Von Ah
Center for Healthy Aging, Self-Management and Complex Care, College of Nursing, The Ohio State University, Columbus, OH 43210, USA
4 shared publications - Emmeline Edwards
National Center for Complementary and Integrative Health, Bethesda, MD, United States
4 shared publications - John Rehner Iversen
McMaster University, Department of Psychology, Neuroscience and Behaviour, Hamilton, Ontario, Canada
4 shared publications
Latest Publications
- 26 August 2026
- Published by SAGE Publications in The Journal of School Nursing
Mind Body Medicine Skills Group Intervention for School Nurse Health and Well-Being: A Pilot Randomized Controlled Trial
School nurses encounter numerous work-related stressors that may affect their health and professional well-being. Guided by the Common Sense Model of Self-Regulation, this pilot randomized controlled trial tested the preliminary effects of an established intervention, mind body medicine skills (MBMS) groups, on school nurses’ health (perceived stress, mental and physical health, and health behaviors) and professional well-being (professional quality of life, workplace wellness support, burnout, and moral distress) compared with a control group. Postintervention, the MBMS group showed improvements relative to controls in health (except in self-rated physical health) and professional well-being and a significant reduction in perceived stress ( d = −0.73, p = .011). The intervention was feasible, and participants judged the coping skills appropriate for students in grades 4–12. These findings support conducting larger trials to evaluate MBMS as a strategy to strengthen school nurses’ well-being and enhance support for the students they serve.
- 26 August 2026
- Published by SAGE Publications in The Journal of School Nursing
Mind Body Medicine Skills Group Intervention for School Nurse Health and Well-Being: A Pilot Randomized Controlled Trial
School nurses encounter numerous work-related stressors that may affect their health and professional well-being. Guided by the Common Sense Model of Self-Regulation, this pilot randomized controlled trial tested the preliminary effects of an established intervention, mind body medicine skills (MBMS) groups, on school nurses’ health (perceived stress, mental and physical health, and health behaviors) and professional well-being (professional quality of life, workplace wellness support, burnout, and moral distress) compared with a control group. Postintervention, the MBMS group showed improvements relative to controls in health (except in self-rated physical health) and professional well-being and a significant reduction in perceived stress ( d = −0.73, p = .011). The intervention was feasible, and participants judged the coping skills appropriate for students in grades 4–12. These findings support conducting larger trials to evaluate MBMS as a strategy to strengthen school nurses’ well-being and enhance support for the students they serve.
- Open Access
- 28 July 2026
- Published by SAGE Publications in Medical Decision Making
- Vol. 46 (8) , 954-972
Effect of Personalized Risk Messages on Patient Intent and Decision Making in Colorectal Cancer Screening: A Randomized Controlled Trial
Purpose: To measure the impact of a personalized message about current risk of having advanced colorectal neoplasia (ACN; colorectal cancer [CRC] or advanced precancerous polyp) on informed concordance and CRC screening decision-making outcomes. Methods: A total of 1,084 patients, aged 50 to 75 y, with an upcoming clinic appointment, due for CRC screening, and at average risk for CRC were randomized to view a decision aid (DA) about CRC screening with or without personalized ACN risk information. Providers were randomized to receive CRC screening notifications with or without each patient’s personalized ACN risk. Patients completed surveys before (T0), immediately after viewing the DA (T1), and after their clinic visit (T2) to assess informed concordance (primary outcome), screening intent, decisional conflict, knowledge, perceived personal risk, and perceived shared decision making. Analysis of covariance and logistic regression models compared intended screening behavior and decision-making outcomes by intervention groups. Results: At T1, participants (mean age 56.5 y, 59.7% female) sent the personalized rather than the generic DA had higher odds of intending to be screened with any test (odds ratio [OR] = 1.55, confidence interval [CI] = 1.03, 2.33) and to have a stool test (OR = 2.17, CI = 1.62, 2.91) and lower odds of intending to undergo colonoscopy (OR = 0.58, CI = 0.43, 0.79). There were no statistically significant effects of either intervention on informed concordance. Moderation analysis, however, showed that for one health system, participants whose provider was sent the personalized notification had higher odds of informed concordance. Limitations: Single Midwestern city, English-speaking patients only, low enrollment of patients at high-average risk for ACN. Conclusion: Providing patients with a personalized message about their ACN risk increased the intent to be screened and to do a stool test and decreased the intent to undergo colonoscopy. For one health system, sending providers the ACN risk message increased the odds of informed concordance. ClinicalTrials.gov: NCT04683731 Highlights: A personalized message about patients’ advanced colorectal neoplasia (ACN) risk, provided as part of a decision aid, increased patients’ intent to be screened with any test and to have a stool test and decreased their intent to be screened with colonoscopy. A personalized message about patients’ ACN risk, included in a decision aid sent to patients or in a screening notification sent to their providers, had no significant effect on informed concordance. At one health system, a personalized message sent to providers about their patients’ ACN risk increased the odds of informed concordance between the patients’ intended screening test and the test received.
- 28 July 2026
- Published by SAGE Publications in Medical Decision Making
- Vol. 46 (8) , 954-972
Open AccessEffect of Personalized Risk Messages on Patient Intent and Decision Making in Colorectal Cancer Screening: A Randomized Controlled Trial
Purpose: To measure the impact of a personalized message about current risk of having advanced colorectal neoplasia (ACN; colorectal cancer [CRC] or advanced precancerous polyp) on informed concordance and CRC screening decision-making outcomes. Methods: A total of 1,084 patients, aged 50 to 75 y, with an upcoming clinic appointment, due for CRC screening, and at average risk for CRC were randomized to view a decision aid (DA) about CRC screening with or without personalized ACN risk information. Providers were randomized to receive CRC screening notifications with or without each patient’s personalized ACN risk. Patients completed surveys before (T0), immediately after viewing the DA (T1), and after their clinic visit (T2) to assess informed concordance (primary outcome), screening intent, decisional conflict, knowledge, perceived personal risk, and perceived shared decision making. Analysis of covariance and logistic regression models compared intended screening behavior and decision-making outcomes by intervention groups. Results: At T1, participants (mean age 56.5 y, 59.7% female) sent the personalized rather than the generic DA had higher odds of intending to be screened with any test (odds ratio [OR] = 1.55, confidence interval [CI] = 1.03, 2.33) and to have a stool test (OR = 2.17, CI = 1.62, 2.91) and lower odds of intending to undergo colonoscopy (OR = 0.58, CI = 0.43, 0.79). There were no statistically significant effects of either intervention on informed concordance. Moderation analysis, however, showed that for one health system, participants whose provider was sent the personalized notification had higher odds of informed concordance. Limitations: Single Midwestern city, English-speaking patients only, low enrollment of patients at high-average risk for ACN. Conclusion: Providing patients with a personalized message about their ACN risk increased the intent to be screened and to do a stool test and decreased the intent to undergo colonoscopy. For one health system, sending providers the ACN risk message increased the odds of informed concordance. ClinicalTrials.gov: NCT04683731 Highlights: A personalized message about patients’ advanced colorectal neoplasia (ACN) risk, provided as part of a decision aid, increased patients’ intent to be screened with any test and to have a stool test and decreased their intent to be screened with colonoscopy. A personalized message about patients’ ACN risk, included in a decision aid sent to patients or in a screening notification sent to their providers, had no significant effect on informed concordance. At one health system, a personalized message sent to providers about their patients’ ACN risk increased the odds of informed concordance between the patients’ intended screening test and the test received.
- Open Access
- 31 October 2025
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 4 (3) , 205-212
Reporting Guidelines for Music-Based Interventions: An update and Validation Study
Background: Detailed intervention reporting is essential to interpretation, replication, and translation of music-based interventions (MBIs). The 2011 Reporting Guidelines for Music-Based Interventions were developed to improve transparency and reporting quality of published research; however, problems with reporting quality persist.Methods: The purpose of this study was to update and validate the 2011 reporting guidelines using rigorous Delphi approach that involved an interdisciplinary group of MBI researchers; and to develop an explanation and elaboration guidance statement to support dissemination and usage. We followed the methodological framework for developing reporting guidelines recommended by the EQUATOR Network and guidance recommendations for developing health research reporting guidelines. Our three-stage process included: (1) an initial field scan, (2) a consensus process using Delphi surveys (two rounds) and Expert Panel meetings, and (3) development and dissemination of an explanation and elaboration document.Results: First-Round survey findings revealed that the original checklist items were capturing content that investigators deemed essential to MBI reporting; however, it also revealed problems with item wording and terminology. Subsequent Expert Panel meetings and the Second-Round survey centered on reaching consensus for item language. The revised RG-MBI checklist has a total of 12-items that pertain to eight different components of MBI interventions including name, theory/scientific rationale, content, interventionist, individual/group, setting, delivery schedule, and treatment fidelity.Conclusion: We recommend that authors, journal editors, and reviewers use the RG-MBI guidelines, in conjunction with methods-based guidelines (e.g., CONSORT) to accelerate and improve the scientific rigor of MBI research.
- 31 October 2025
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 4 (3) , 205-212
Open AccessReporting Guidelines for Music-Based Interventions: An update and Validation Study
Background: Detailed intervention reporting is essential to interpretation, replication, and translation of music-based interventions (MBIs). The 2011 Reporting Guidelines for Music-Based Interventions were developed to improve transparency and reporting quality of published research; however, problems with reporting quality persist.Methods: The purpose of this study was to update and validate the 2011 reporting guidelines using rigorous Delphi approach that involved an interdisciplinary group of MBI researchers; and to develop an explanation and elaboration guidance statement to support dissemination and usage. We followed the methodological framework for developing reporting guidelines recommended by the EQUATOR Network and guidance recommendations for developing health research reporting guidelines. Our three-stage process included: (1) an initial field scan, (2) a consensus process using Delphi surveys (two rounds) and Expert Panel meetings, and (3) development and dissemination of an explanation and elaboration document.Results: First-Round survey findings revealed that the original checklist items were capturing content that investigators deemed essential to MBI reporting; however, it also revealed problems with item wording and terminology. Subsequent Expert Panel meetings and the Second-Round survey centered on reaching consensus for item language. The revised RG-MBI checklist has a total of 12-items that pertain to eight different components of MBI interventions including name, theory/scientific rationale, content, interventionist, individual/group, setting, delivery schedule, and treatment fidelity.Conclusion: We recommend that authors, journal editors, and reviewers use the RG-MBI guidelines, in conjunction with methods-based guidelines (e.g., CONSORT) to accelerate and improve the scientific rigor of MBI research.
- Open Access
- 31 October 2025
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 4 (3) , 190-204
Reporting Guidelines for Music-Based Interventions Checklist: Explanation and Elaboration Guide
Background: Detailed intervention reporting is essential to interpretation, replication, and eventual translation of music-based interventions (MBIs) into practice. Despite availability of Reporting Guidelines for Music-based Interventions (RG-MBI, published 2011), multiple reviews reveal sustained problems with reporting quality and consistency. To address this, we convened an interdisciplinary expert panel to update and improve the utility and validity of the existing guidelines using a rigorous Delphi approach. The resulting updated checklist includes 12-items across eight areas considered essential to ensure transparent reporting of MBIs.Methods: The purpose of this explanation and elaboration document is to facilitate consistent understanding, use, and dissemination of the revised RG-MBI. Members of the interdisciplinary expert panel collaborated to create the resulting guidance statement.Results: This guidance statement offers: (1) the scope and intended use of the RG-MBI, (2) an explanation for each checklist item, with examples from published studies, and (3) 2 published studies with annotations indicating where the authors reported each checklist item.Conclusion: Broader uptake of the RG-MBIs by study authors, editors, and peer reviewers will lead to better reporting of MBI trials, and in turn facilitate greater replication of research, improve cross-study comparisons and meta-analyses, and increase implementation of findings.
- 31 October 2025
- Published by Jaseng Medical Foundation in Perspectives on Integrative Medicine
- Vol. 4 (3) , 190-204
Open AccessReporting Guidelines for Music-Based Interventions Checklist: Explanation and Elaboration Guide
Background: Detailed intervention reporting is essential to interpretation, replication, and eventual translation of music-based interventions (MBIs) into practice. Despite availability of Reporting Guidelines for Music-based Interventions (RG-MBI, published 2011), multiple reviews reveal sustained problems with reporting quality and consistency. To address this, we convened an interdisciplinary expert panel to update and improve the utility and validity of the existing guidelines using a rigorous Delphi approach. The resulting updated checklist includes 12-items across eight areas considered essential to ensure transparent reporting of MBIs.Methods: The purpose of this explanation and elaboration document is to facilitate consistent understanding, use, and dissemination of the revised RG-MBI. Members of the interdisciplinary expert panel collaborated to create the resulting guidance statement.Results: This guidance statement offers: (1) the scope and intended use of the RG-MBI, (2) an explanation for each checklist item, with examples from published studies, and (3) 2 published studies with annotations indicating where the authors reported each checklist item.Conclusion: Broader uptake of the RG-MBIs by study authors, editors, and peer reviewers will lead to better reporting of MBI trials, and in turn facilitate greater replication of research, improve cross-study comparisons and meta-analyses, and increase implementation of findings.
- 1 October 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (10) , 1390-1399
Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening
Providing personalized risk information to patients and their providers could improve colorectal cancer (CRC) screening. To determine whether providing information on patient risk for advanced colorectal neoplasia (ACN; which includes CRC and advanced precancerous lesions) to patients and providers affects screening uptake, and to identify effect moderators. Randomized controlled trial (2 × 2 factorial design). (ClinicalTrials.gov: NCT04683731). Primary care clinics in 2 health care systems. 214 providers and 1084 average-risk patients due for screening. Participants were randomly assigned to view a CRC screening decision aid with or without a personalized message about ACN risk. Providers were randomly assigned to receive notifications that the patient was due for screening, with or without a personalized message about the patient's ACN risk. Screening test completion by 6 months. Logistic regression was used to estimate intervention effects. Overall, there were no differences in screening uptake or test completion for the provider notification (predicted probabilities, 41.5% vs. 36.4% for personalized vs. generic; difference, 5.1 [95% CI, -1.6 to 11.8] percentage points) or decision aid (predicted probabilities, 36.8% vs. 41.0% for personalized vs. generic; difference, -4.1 [CI, -10.2 to 1.9] percentage points) interventions. Health system was an effect moderator for stool testing. For one health system, the stool testing rate was higher for personalized versus generic provider notification (predicted probabilities, 21.1% vs. 7.9%; difference, 13.2 [CI, 1.6 to 24.8] percentage points) when the decision aid was generic. The stool testing rate was higher for the personalized versus the generic decision aid (predicted probabilities, 21.4% vs. 7.9%; difference, 13.5 [CI, 2.4 to 24.5] percentage points) when the provider notification was generic. Few participants had high-average ACN risk. Non-English-speaking patients were excluded. Although including personalized risk for ACN in a decision aid or provider notification had no overall effect, it increased uptake of stool testing in one health system. Patient-Centered Outcomes Research Institute (PCORI).
- 1 October 2025
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 178 (10) , 1390-1399
Effect of Personalized Risk Messages on Uptake of Colorectal Cancer Screening
Providing personalized risk information to patients and their providers could improve colorectal cancer (CRC) screening. To determine whether providing information on patient risk for advanced colorectal neoplasia (ACN; which includes CRC and advanced precancerous lesions) to patients and providers affects screening uptake, and to identify effect moderators. Randomized controlled trial (2 × 2 factorial design). (ClinicalTrials.gov: NCT04683731). Primary care clinics in 2 health care systems. 214 providers and 1084 average-risk patients due for screening. Participants were randomly assigned to view a CRC screening decision aid with or without a personalized message about ACN risk. Providers were randomly assigned to receive notifications that the patient was due for screening, with or without a personalized message about the patient's ACN risk. Screening test completion by 6 months. Logistic regression was used to estimate intervention effects. Overall, there were no differences in screening uptake or test completion for the provider notification (predicted probabilities, 41.5% vs. 36.4% for personalized vs. generic; difference, 5.1 [95% CI, -1.6 to 11.8] percentage points) or decision aid (predicted probabilities, 36.8% vs. 41.0% for personalized vs. generic; difference, -4.1 [CI, -10.2 to 1.9] percentage points) interventions. Health system was an effect moderator for stool testing. For one health system, the stool testing rate was higher for personalized versus generic provider notification (predicted probabilities, 21.1% vs. 7.9%; difference, 13.2 [CI, 1.6 to 24.8] percentage points) when the decision aid was generic. The stool testing rate was higher for the personalized versus the generic decision aid (predicted probabilities, 21.4% vs. 7.9%; difference, 13.5 [CI, 2.4 to 24.5] percentage points) when the provider notification was generic. Few participants had high-average ACN risk. Non-English-speaking patients were excluded. Although including personalized risk for ACN in a decision aid or provider notification had no overall effect, it increased uptake of stool testing in one health system. Patient-Centered Outcomes Research Institute (PCORI).
- Open Access
- 17 July 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 14 (3) , 101200
Reporting guidelines for music-based interventions checklist: Explanation and elaboration guide
- 17 July 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 14 (3) , 101200
Open AccessReporting guidelines for music-based interventions checklist: Explanation and elaboration guide
- Open Access
- 15 July 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 14 (3) , 101199
Reporting guidelines for music-based interventions: An update and validation study
- 15 July 2025
- Published by Elsevier in Integrative Medicine Research
- Vol. 14 (3) , 101199
Open AccessReporting guidelines for music-based interventions: An update and validation study
- Open Access
- 10 April 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (5) , 1-10
The role of glycemic control and symptoms and symptom clusters in breast cancer survivors with type 2 diabetes
Purpose: The purpose of the study was to describe the type and number of symptoms and examine symptom clusters of breast cancer survivors (BCS) with diabetes (type 2) by glycemic control (HbA1c < 7 or ≥ 7%). Methods: A retrospective cohort study was conducted. Symptom data were extracted from clinical notes in the electronic health record. BCS (stage I-III) diagnosed between 2007 and 2019 had diabetes, and at least one HbA1c within 8 months of initial chemotherapy was included. Zero-inflated negative binomial regression analysis was used to examine total symptoms by glycemic control. Exploratory factor analysis was conducted to identify symptom clusters. Results: Three hundred twenty-seven BCS met the inclusion criteria. Two symptom clusters were identified in BCS with HbA1c ≥ 7%: a psychoneurological cluster (anxiety, fatigue, peripheral neuropathy, and depression) and a gastrointestinal cluster (vomiting, nausea, and constipation). Two symptom clusters were identified in BCS with HbA1c < 7% a mixed gastrointestinal/psychoneurological cluster (vomiting, nausea, peripheral neuropathy, fatigue, and constipation) and a mental health symptom cluster (depression and anxiety). Conclusion: The symptom clusters of BCS differed by glycemic control. Prospective research studies are needed to examine the role of glycemic control in symptoms in BCS with diabetes. Understanding the influence of glycemic control can help providers identify BCS at high risk for troublesome symptoms and symptom clusters, thereby facilitating interventions that target glycemic control, potentially mitigating symptoms, and symptom clusters, and improving outcomes for BCS with diabetes.
- 10 April 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (5) , 1-10
Open AccessThe role of glycemic control and symptoms and symptom clusters in breast cancer survivors with type 2 diabetes
Purpose: The purpose of the study was to describe the type and number of symptoms and examine symptom clusters of breast cancer survivors (BCS) with diabetes (type 2) by glycemic control (HbA1c < 7 or ≥ 7%). Methods: A retrospective cohort study was conducted. Symptom data were extracted from clinical notes in the electronic health record. BCS (stage I-III) diagnosed between 2007 and 2019 had diabetes, and at least one HbA1c within 8 months of initial chemotherapy was included. Zero-inflated negative binomial regression analysis was used to examine total symptoms by glycemic control. Exploratory factor analysis was conducted to identify symptom clusters. Results: Three hundred twenty-seven BCS met the inclusion criteria. Two symptom clusters were identified in BCS with HbA1c ≥ 7%: a psychoneurological cluster (anxiety, fatigue, peripheral neuropathy, and depression) and a gastrointestinal cluster (vomiting, nausea, and constipation). Two symptom clusters were identified in BCS with HbA1c < 7% a mixed gastrointestinal/psychoneurological cluster (vomiting, nausea, peripheral neuropathy, fatigue, and constipation) and a mental health symptom cluster (depression and anxiety). Conclusion: The symptom clusters of BCS differed by glycemic control. Prospective research studies are needed to examine the role of glycemic control in symptoms in BCS with diabetes. Understanding the influence of glycemic control can help providers identify BCS at high risk for troublesome symptoms and symptom clusters, thereby facilitating interventions that target glycemic control, potentially mitigating symptoms, and symptom clusters, and improving outcomes for BCS with diabetes.
- 16 August 2024
- Published by Elsevier in Geriatric Nursing
- Vol. 59, 543-548
Factors associated with change in activities of daily living performance in home health care patients with diabetes
- 16 August 2024
- Published by Elsevier in Geriatric Nursing
- Vol. 59, 543-548
Factors associated with change in activities of daily living performance in home health care patients with diabetes